BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 31132496)

  • 1. Hearing Preservation for Vestibular Schwannomas Treated with Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy.
    Udawatta M; Kwan I; Preet K; Nguyen T; Ong V; Sheppard JP; Duong C; Romiyo P; Lee P; Tenn S; Kaprealian T; Gopen Q; Yang I
    World Neurosurg; 2019 Sep; 129():e303-e310. PubMed ID: 31132496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
    Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
    J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
    Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
    Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery.
    Anderson BM; Khuntia D; Bentzen SM; Geye HM; Hayes LL; Kuo JS; Baskaya MK; Badie B; Basavatia A; Pyle GM; Tomé WA; Mehta MP
    J Neurooncol; 2014 Jan; 116(1):187-93. PubMed ID: 24142200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
    van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
    Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome.
    Combs SE; Welzel T; Kessel K; Habermehl D; Rieken S; Schramm O; Debus J
    Radiother Oncol; 2013 Feb; 106(2):175-80. PubMed ID: 23333012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
    Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas.
    Carlson ML; Vivas EX; McCracken DJ; Sweeney AD; Neff BA; Shepard NT; Olson JJ
    Neurosurgery; 2018 Feb; 82(2):E35-E39. PubMed ID: 29309683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractionated vs. single-fraction stereotactic radiotherapy in patients with vestibular schwannoma : Hearing preservation and patients' self-reported outcome based on an established questionnaire.
    Kessel KA; Fischer H; Vogel MM; Oechsner M; Bier H; Meyer B; Combs SE
    Strahlenther Onkol; 2017 Mar; 193(3):192-199. PubMed ID: 27803960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss.
    Rasmussen R; Claesson M; Stangerup SE; Roed H; Christensen IJ; Cayé-Thomasen P; Juhler M
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e607-11. PubMed ID: 22560549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
    Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
    J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINAC-based stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy delivered in 3 or 5 fractions for vestibular schwannomas: comparative assessment from a single institution.
    Söderlund Diaz L; Hallqvist A
    J Neurooncol; 2020 Apr; 147(2):351-359. PubMed ID: 32036575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas - pooled results from 3 large German centers.
    Combs SE; Engelhard C; Kopp C; Wiedenmann N; Schramm O; Prokic V; Debus J; Molls M; Grosu AL
    Radiother Oncol; 2015 Mar; 114(3):378-83. PubMed ID: 25702864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hearing Outcomes After Stereotactic Radiosurgery for Vestibular Schwannomas : Mechanism of Hearing Loss and How to Preserve Hearing.
    Han JH; Kim DG; Chung HT; Paek SH; Jung HW
    Adv Tech Stand Neurosurg; 2016; (43):3-36. PubMed ID: 26508404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities.
    Lo A; Ayre G; Ma R; Hsu F; Akagami R; McKenzie M; Valev B; Gete E; Vallieres I; Nichol A
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):443-451. PubMed ID: 29066124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractionated stereotactic radiation therapy for vestibular schwannomas: Dosimetric factors predictive of hearing outcomes.
    Bennion NR; Nowak RK; Lyden ER; Thompson RB; Li S; Lin C
    Pract Radiat Oncol; 2016; 6(5):e155-e162. PubMed ID: 26961715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrospective Cohort Study of Longitudinal Audiologic Assessment in Single and Fractionated Stereotactic Radiosurgery for Vestibular Schwannoma.
    Khattab MH; Sherry AD; Whitaker R; Wharton DM; Weaver KD; Chambless LB; Cmelak AJ; Attia A
    Neurosurgery; 2019 Dec; 85(6):E1078-E1083. PubMed ID: 31215628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hearing preservation after Gamma Knife radiosurgery for cerebellopontine angle meningiomas.
    El-Shehaby AMN; Reda WA; Abdel Karim KM; Nabeel AM; Emad Eldin RM; Tawadros SR
    J Neurosurg; 2018 Dec; 129(Suppl1):38-46. PubMed ID: 30544298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linac-based stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannomas: comparative observations of 139 patients treated at a single institution.
    Puataweepong P; Dhanachai M; Dangprasert S; Narkwong L; Sitathanee C; Sawangsilpa T; Janwityanujit T; Yongvithisatid P
    J Radiat Res; 2014 Mar; 55(2):351-8. PubMed ID: 24142966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A matched cohort comparison of clinical outcomes following microsurgical resection or stereotactic radiosurgery for patients with small- and medium-sized vestibular schwannomas.
    Golfinos JG; Hill TC; Rokosh R; Choudhry O; Shinseki M; Mansouri A; Friedmann DR; Thomas Roland J; Kondziolka D
    J Neurosurg; 2016 Dec; 125(6):1472-1482. PubMed ID: 27035174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.